Boenning & Scattergood’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.28M Buy
14,304
+8,358
+141% +$490K 0.21% 125
2022
Q3
$342K Sell
5,946
-8,361
-58% -$548K 0.07% 273
2022
Q2
$966K Buy
14,307
+3
+0% +$230 0.18% 136
2022
Q1
$1.28M Buy
14,304
+56
+0.4% +$4.92K 0.21% 125
2021
Q4
$1.26M Buy
14,248
+96
+0.7% +$7.72K 0.2% 124
2021
Q3
$1.05M Buy
14,152
+2
+0% +$148 0.18% 136
2021
Q2
$980K Hold
14,150
0.17% 148
2021
Q1
$1.1M Hold
14,150
0.21% 126
2020
Q4
$1.16M Sell
14,150
-25
-0.2% -$1.9K 0.25% 108
2020
Q3
$984K Hold
14,175
0.24% 106
2020
Q2
$805K Buy
14,175
+8,365
+144% +$449K 0.21% 115
2020
Q1
$270K Hold
5,810
0.09% 215
2019
Q4
$360K Buy
5,810
+725
+14% +$44.8K 0.09% 228
2019
Q3
$306K Hold
5,085
0.09% 220
2019
Q2
$323K Buy
5,085
+25
+0.5% +$1.64K 0.09% 214
2019
Q1
$366K Buy
5,060
+500
+11% +$35K 0.11% 205
2018
Q4
$289K Sell
4,560
-500
-10% -$34.8K 0.1% 214
2018
Q3
$391K Hold
5,060
0.12% 189
2018
Q2
$399K Buy
+5,060
New +$398K 0.13% 187

Other funds holding CTSH

Boenning & Scattergood's CTSH Position: Q4 2022 in Review

Boenning & Scattergood increased its Cognizant (CTSH) stake by 141% in Q4 2022, buying an estimated $490K and bringing the position to 14,304 shares worth $1.28M. The position accounts for 0.21% of the portfolio, ranked #125.

Boenning & Scattergood first reported a position in CTSH in Q2 2018 and has held it in 19 quarters since. 865 funds tracked by Wall St. Rank hold CTSH as of Q4 2022.

  • Boenning & Scattergood held 14,304 shares of Cognizant worth $1.28M as of Q4 2022.
  • Boenning & Scattergood bought 8,358 Cognizant shares in Q4 2022, an estimated $490K.
  • Cognizant made up 0.21% of Boenning & Scattergood's portfolio in Q4 2022, its #125 holding.
  • Boenning & Scattergood first reported a position in Cognizant in Q2 2018 and has held it in 19 quarters since.
  • 865 funds tracked by Wall St. Rank held Cognizant as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.